DC's latest theatrical experiment, Clayface, is making waves—not just for its body-horror thrills, but for how it's defying typical superhero box office patterns. After two weeks in release, the film has seen its first major theater count drop, losing 532 screens heading into its third weekend. While that might sound alarming, the numbers tell a more nuanced story.
Unlike the front-loaded openings of most horror titles, Clayface has enjoyed a steadier run, buoyed by strong word-of-mouth and a rare double-digit approval from both critics and audiences. The film currently holds a 78% Certified Fresh score on Rotten Tomatoes, with an audience score of 94% Verified Hot—a near-unheard-of feat for the genre. The site's consensus praises it as a film that "carves out a unique identity for itself in the DCU while closely resembling a litany of body horror classics," eventually morphing into "an icky and satisfying revenge thriller."
Financially, Clayface has grossed $92 million globally against a reported budget of just $44 million, making it a clear success for DC Studios. It's currently playing in 3,946 theaters, down from its opening count of 3,478—a modest contraction compared to the steep drop experienced by this summer's Supergirl, which lost 1,100 screens in its third week and ultimately ended its run with $125 million worldwide on a $180 million budget.
The contrast between the two films highlights the different strategies at play in the new DCU. While Supergirl aimed for blockbuster scale, Clayface is a leaner, genre-driven anti-hero story in the vein of Joker. Directed by James Watkins and starring Tom Rhys Harries, Naomi Ackie, Max Minghella, and Eddie Marsan, the film has become a talking point for how the franchise is willing to take risks beyond the traditional superhero mold.
For fans of the genre, Clayface offers a refreshing change of pace. Its success also bodes well for future DCU experiments, especially as the franchise prepares for Man of Tomorrow, starring David Corenswet as Superman and Nicholas Hoult as Lex Luthor, slated for July 2027. Milly Alcock, who played Supergirl, is expected to return in that film.
As Clayface continues its theatrical run, it's worth noting that its performance mirrors other recent genre hits that have found new life on streaming. For instance, Evil Dead Burn has been a streaming sensation on HBO Max, proving that horror thrives beyond the multiplex. Similarly, Netflix's revenge thriller My Name has drawn comparisons to John Wick and Kill Bill, showing the enduring appeal of gritty, character-driven action.
While Clayface may not be breaking records like a traditional superhero tentpole, its controlled decline and strong audience reception suggest it's exactly the kind of experiment the DCU needs. Whether it's a one-off or a sign of things to come, it's clear that horror and superheroes can coexist—and even thrive—together.
Stay tuned for more updates on Clayface and the future of the DCU.
